title: The metabolism of fatty acids in human Bietti crystalline dystrophy.
abstract: OBJECTIVE
  To investigate the role of abnormal lipid metabolism in Bietti crystalline dystrophy.
  
  
  METHODS
  Cultured human lymphocytes and fibroblasts from patients with Bietti crystalline dystrophy (BCD) were incubated in the presence of [(14)C]18:3n-3 or [(14)C]18:2n-6. Incorporation into the cellular lipid pools and further metabolism by desaturation or elongation were monitored by thin-layer chromatography and HPLC. Results were compared with those in normal control subjects and patients with Wolman disease (WD).
  
  
  RESULTS
  Pulse-chase experiments with labeled fatty acids in all groups showed that, after 1 hour, radioactivity was largely confined to the triacylglyceride (TG) and choline phosphoglyceride (CPG) pools. However, after several hours, radioactivity was transferred from the TG and CPG pools, some going to the serine and ethanolamine phosphoglyceride (SPG and EPG) pools. Fibroblasts from all groups showed direct transfer of fatty acids (FAs) into CPG and EPG. Incorporation of labeled FAs into the EPG pool paralleled extensive desaturation and elongation of 18:2n-6 to 22:5n-6 and 18:3n-3 to 22:6n-3. Fibroblasts from patients with WD (a lysosomal acid lipase deficiency characterized by excessive lipid accumulation), showed higher incorporation of 18:2n-6 into TGs than did normal or BCD fibroblasts. Conversely, fibroblasts from patients with BCD showed lower conversion of 18:3n-3, but not of 18:2n-6, into polyunsaturated FAs (PUFAs) than those of normal subjects or patients with WD. This was true for total FAs, CPGs, and EPGs. Similar results were found in both fibroblasts and lymphocytes; however, unlike fibroblasts, lymphocytes from normal subjects showed similar levels of incorporation of FAs into EPGs and CPGs. In contrast, incorporation of 18:3n-3 into EPGs was decreased in lymphocytes from patients with BCD.
  
  
  CONCLUSIONS
  BCD is characterized by a lower than normal conversion of FA precursors into n-3 PUFA, whereas there is a higher than normal level of n-6 and n-3 FAs incorporation into TGs in cells from patients with WD. These findings raise the possibility that abnormal lipid metabolism associated with BCD is the result of deficient lipid binding, elongation, or desaturation in contrast to the lysosomal acid lipase deficiency found in Wolman disease.
authors: Ophthalmic Genetics and Clinical Services Branch, National Eye Institute, National Institutes of Health, 10 Center Drive MSC 1860, Bethesda, MD 20892, USA.
authors: J
authors: J
authors: Lee
authors: X
authors: X
authors: Jiao
authors: J F
authors: JF
authors: Hejtmancik
authors: M
authors: M
authors: Kaiser-Kupfer
authors: W A
authors: WA
authors: Gahl
authors: T C
authors: TC
authors: Markello
authors: J
authors: J
authors: Guo
authors: G J
authors: GJ
authors: Chader
mesh_terms: D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D005227:Fatty Acids / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism / Q000473:pathology; D010713:Phosphatidylcholines / Q000378:metabolism; D012162:Retinal Degeneration / Q000378:metabolism* / Q000473:pathology; D014280:Triglycerides / Q000378:metabolism
chemical_list: D005227:Fatty Acids; D010713:Phosphatidylcholines; D014280:Triglycerides